ARYA Sciences Acquisition Corp IV
Cash in trust
$37.1M
$37,119,896
Trust per share
—
Redemption value
IPO
Mar 2021
$150M raised
Combination deadline
—
Not disclosed
Filings on record
138
Latest Aug 12, 2024
Business combination
- Target
- Not disclosed in an indexed filing
- Announced
- Sep 29, 2021
- Closed
- Aug 12, 2024
Overview
ARYA Sciences Acquisition Corp IV is a special purpose acquisition company incorporated in Cayman Islands and registered with the SEC under CIK 0001838821. It completed its initial public offering in Mar 2021, raising $150M in gross proceeds. The vehicle is sponsored by ARYA Sciences Holdings IV, a Islands exempted through ARYA Sciences Holdings IV, a Cayman Islands exempted limited. The mandate targets healthcare. Business combination closed; the company trades under a new ticker.
“we intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare related industries.”
Reading the filings
Arithmetic on what ARYA Sciences Acquisition Corp IV has disclosed, written the way a desk would read it. These are observations, not a rating. Nothing here scores the vehicle or implies a view on it.
Extension history
Shareholders have already approved 2 extensions. Each one opened a redemption window, so the public float and the trust are almost certainly smaller than at IPO, and each typically came with a sponsor contribution that lifts trust per share. A vehicle on its second or third extension is one where the sponsor is paying to keep the search alive.
Sponsor record
ARYA Sciences Holdings IV, a Islands exempted has launched 2 vehicles. Of the 2 that have resolved, 2 closed a combination and 0 liquidated, a 100% completion rate. A sponsor's record is not a forecast, but it does tell you whether the team has taken a deal across the line before.
Underwriting
Goldman Sachs led the offering. It has been named on 97 SPAC IPOs, book-running 59 of them, and 58.3% of its resolved vehicles closed a deal. The syndicate has no control over whether a sponsor finds a target, but the quality of the book at pricing shapes who ends up holding the units.
At every shareholder vote holders may hand their shares back for their cash. Each bar is one vote, read out of the 8-K that reported it.
14M shares handed back across 3 votes.
Filings per month since the first one. A vehicle that has gone quiet with a deadline ahead is a different proposition from one that is still working.
128 filings in all. 18 in the last three months, against a busiest month of 20.
News on ARYA Sciences Acquisition Corp IV
Last 90 daysNothing in the last 90 days that names this vehicle. We attribute a story only when the release carries the ticker or the registered name, so an empty section means no press release or wire story matched — not that nothing was published. The filings below are the primary record either way.
SEC filing history
Free tier: filings older than 24 hours- 15-12G
Deregistration of securities
Accession 0001140361-24-036853
- 4
Statement of changes in beneficial ownership
Accession 0001140361-24-035180
- 4
Statement of changes in beneficial ownership
Accession 0001140361-24-035178
- 4
Statement of changes in beneficial ownership
Accession 0001140361-24-035176
- 4
Statement of changes in beneficial ownership
Accession 0001140361-24-035174
- 4
Statement of changes in beneficial ownership
Accession 0001140361-24-035172
- 4
Statement of changes in beneficial ownership
Accession 0001140361-24-035170
- 4
Statement of changes in beneficial ownership
Accession 0001140361-24-035169
- 4
Statement of changes in beneficial ownership
Accession 0001140361-24-035164
- 25-NSE
Notification of delisting
Accession 0001354457-24-000541
- 8-K
Submission of matters to a vote of security holders
Item 5.07 · Accession 0001140361-24-034408
- 8-K
Other events
Item 8.01 · Accession 0001140361-24-033881
- DEFM14A
Definitive merger proxy statement
Accession 0001140361-24-033082
- 8-K
Entry into a material definitive agreement; Other events
Items 1.01, 2.03, 8.01, 9.01 · Accession 0001140361-24-032091
- SC 13G/A
SC 13G/A
Accession 0001104659-24-076360
- 8-K
Entry into a material definitive agreement
Items 1.01, 3.02, 9.01 · Accession 0001140361-24-031248
- 8-K
Regulation FD disclosure
Items 7.01, 9.01 · Accession 0001140361-24-029728
- 8-K
Other events
Items 2.03, 8.01, 9.01 · Accession 0001140361-24-028438
- 10-Q/A
10-Q/A
Accession 0001140361-24-026933
- 10-Q
Quarterly report
Accession 0001140361-24-026910
- NT 10-Q
Late quarterly report notification
Accession 0001140361-24-026468
- SC 13G/A
Amended beneficial ownership report (passive)
Accession 0001076809-24-000088
- 8-K
Other events
Items 2.03, 8.01, 9.01 · Accession 0001140361-24-024030
- 8-K
Other events
Items 8.01, 9.01 · Accession 0001140361-24-023817
- 425
Business-combination communication
Accession 0001140361-24-021476
- 8-K
Regulation FD disclosure
Items 7.01, 9.01 · Accession 0001140361-24-021472
- 425
Business-combination communication
Accession 0001140361-24-017085
- 8-K
Other events
Items 2.03, 8.01, 9.01 · Accession 0001140361-24-017083
- 10-K
Annual report
Accession 0001140361-24-016377
- 425
Business-combination communication
Accession 0001140361-24-016374
Pro
Track ARYA Sciences Acquisition Corp IV without the delay
Free accounts see this filing history a day late. Pro shows every document minutes after EDGAR publishes it, opens it on EDGAR in one click, and adds the twelve-month deadline calendar.
- Filings live, no 24-hour delay
- One click through to the source document
- Deadline calendar out to 12 months
- CSV export, API and MCP access
Cancel any time. Billed monthly in USD.
ARYA Sciences Acquisition Corp IV: questions answered
What is ARYA Sciences Acquisition Corp IV?
ARYA Sciences Acquisition Corp IV is a special purpose acquisition company incorporated in Cayman Islands and registered with the SEC under CIK 0001838821. It completed its initial public offering in Mar 2021, raising $150M in gross proceeds. The vehicle is sponsored by ARYA Sciences Holdings IV, a Islands exempted through ARYA Sciences Holdings IV, a Cayman Islands exempted limited. The mandate targets healthcare. Business combination closed; the company trades under a new ticker.
How much does ARYA Sciences Acquisition Corp IV hold in trust?
Approximately $37,119,896, as at the most recent filing on record. Trust balances move: shareholders redeem at extension votes and at the combination vote, and sponsors pay contributions in to extend. Treat the figure as a point-in-time disclosure, not a running balance.
When must ARYA Sciences Acquisition Corp IV complete a merger?
No combination deadline appears in the filings we have indexed. The date is stated in the charter and repeated in each quarterly report; where our parser could not establish it with confidence we leave it blank rather than infer one.
What happens if ARYA Sciences Acquisition Corp IV does not find a target in time?
The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.
Can I redeem shares in ARYA Sciences Acquisition Corp IV, and at what price?
Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.
Is the trust value the same as the share price for ARYA Sciences Acquisition Corp IV?
No. Trust per share is a disclosed, contractual figure: what a redeeming holder receives. The market price is whatever the shares change hands at, which can sit above the trust when a deal is well received or below it when the market doubts one will close. We do not have a current quote for this vehicle, so no spread is shown.
How much dilution do ARYA Sciences Acquisition Corp IV's founder shares and warrants create?
Both are disclosed in the prospectus and both survive into the combined company, which is why a de-SPAC at $10 is not economically the same as an IPO at $10.
Who sponsors ARYA Sciences Acquisition Corp IV, and what is their track record?
ARYA Sciences Holdings IV, a Cayman Islands exempted limited is the sponsor entity, part of the ARYA Sciences Holdings IV, a Islands exempted franchise. That franchise has launched 2 vehicles in total, of which 2 closed a combination and 0 liquidated, a 100% completion rate on resolved vehicles. Named principals: Adam Stone, Joseph Edelman.
Which banks underwrote the ARYA Sciences Acquisition Corp IV IPO?
Goldman Sachs, Jefferies. Goldman Sachs and Jefferies were credited as book-running managers on the cover. Syndicate membership and role are read from the prospectus cover and the underwriting section.
Is ARYA Sciences Acquisition Corp IV a good investment?
That is not a question this site answers. ARYA Sciences Acquisition Corp IV is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.
Where does this ARYA Sciences Acquisition Corp IV data come from?
Filings ARYA Sciences Acquisition Corp IV submitted to the SEC under CIK 0001838821: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.
Compiled by the SPACListing research desk
Last reconciled Oct 19, 2026
Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.
Read the full methodology · What is in the dataset · Report a correction
SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.
Continue reading
The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.
ARYA Sciences Holdings IV, a Islands exempted: the full record
Every vehicle this sponsor has launched, what closed, what liquidated and what is still live.
Goldman Sachs in SPACs
Mandates, bookrun credit, deal volume and the outcome of the vehicles it priced.
Healthcare SPACs
Every vehicle chasing the same mandate, ranked by cash in trust.
All completed de-spac transactions
Business combination closed; the company trades under a new ticker.
Deadline calendar
Which sponsors are running out of time, and when the extension votes land.
What is a SPAC?
The structure, the economics and where the risks actually sit.
SPAC glossary
Every term in a blank-check filing, defined the way practitioners use it.
How this data is built
Coverage universe, ingestion, normalisation, lifecycle classification and known limits.